By attending this activity, participants will be able to:
Describe new evidence in curative therapy for sickle cell disease and thalassemia.
Discuss optimal approaches to diagnostic and genetic testing in hemoglobinopathies.
Apply current evidence in prevention and treatment of stroke and thrombosis in hemoglobinopathies.
Manage complex cases, including iron overload, non-transfusion dependent thalassemia and sickle cell disease.